PDC-1421 Capsule
BLI-1008-002
Phase 2 small_molecule completed
Quick answer
PDC-1421 Capsule for Attention-Deficit Hyperactivity Disorder (ADHD) is a Phase 2 program (small_molecule) at ABVC BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ABVC BIOPHARMA, INC.
- Indication
- Attention-Deficit Hyperactivity Disorder (ADHD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed